Back to top
more

State Street SPDR S&P Semiconductor ETF: (XSD)

(Real Time Quote from BATS) As of Nov 6, 2026 02:38 PM ET

$413.63 USD

413.63
253,698

+20.50 (5.22%)

Volume: 253,698

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

2 - Buy of 5   2      

Zacks News

Zacks Equity Research

Should You Invest in the SPDR S&P Semiconductor ETF (XSD)?

Sector ETF report for XSD

Sanghamitra Saha headshot

5 ETFs to Cash In On Record High U.S. Household Net Worth

The net worth of American households touched a fresh all-time high in the second quarter.

Sweta Jaiswal, FRM headshot

Here's Why Semiconductor ETFs Are Looking Attractive for Q4

The semiconductor industry continues to be strong amid the coronavirus crisis as increasing inclination toward digitization is driving demand for semiconductor chips.

Zacks Equity Research

The Zacks Analyst Blog Highlights: SOXX, SMH, XSD, PSI and FTXL

The Zacks Analyst Blog Highlights: SOXX, SMH, XSD, PSI and FTXL

Sweta Killa headshot

Semiconductor ETFs Soaring to New Heights

Semiconductor ETFs have been rallying this year and are hitting new peaks on several occasions.

Sweta Killa headshot

Semiconductor ETF (XSD) Hits New 52-Week High

This semiconductor ETF hits a new 52-week high. Are more gains in store for this ETF?

Sweta Jaiswal, FRM headshot

5 Top-Ranked ETFs That Outperformed in August

Let's take a look at some top-ranked ETFs that outperformed Wall Street in August.

Sanghamitra Saha headshot

Fearing a September Slump? Buy These 5 ETFs

September is historically the worst month of the year for stocks. But this September could be different with these stock picks.

Neena Mishra headshot

4 Chip ETFs You Should Not Ignore

Semiconductor ETFs surged after blockbuster earnings.

Sanghamitra Saha headshot

6 Best ETF Areas of August

Optimism about corporate earnings, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine, some upbeat economic data points and the passage of the infrastructure bill helped key U.S. equity indexes go higher in August.